We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
38 hedge funds and large institutions have $206M invested in Larimar Therapeutics in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
24% more capital invested
Capital invested by funds: $166M → $206M (+$39.9M)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
4.37% more ownership
Funds ownership: 84.33% → 88.7% (+4.4%)
3% more funds holding
Funds holding: 37 → 38 (+1)
Holders
38
Holders Change
+1
Holders Change %
+2.7%
% of All Funds
0.77%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
6
Increased
11
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$693K |
| 2 |
O
OrbiMed
New York
|
-$600K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$596K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$259K |
| 5 |
SCM
Sio Capital Management
New York
|
-$224K |
